XORTX Therapeutics Inc. (XRTX) (CIK 0001729214) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001104659-26-014490
- Form
- CORRESP
- Filer
- XORTX Therapeutics Inc. (XRTX) (CIK 0001729214)
- CIK
- 0001729214
- Ticker
- XRTX
- Filed
- 2026-02-12
- SIC industry
- 2834
- HQ
- Vancouver, A1
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1729214/000110465926014490/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗